Clinical Trials Directory

Trials / Completed

CompletedNCT02451904

Severe and Cerebral Malaria Investigated Through Host Metabolomics

Microvascular and Metabolic Dysregulation in the Pathogenesis of Severe and Cerebral Malaria Investigated Through Host Metabolomics

Status
Completed
Phase
Study type
Observational
Enrollment
840 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

* The aim is to describe disease mechanisms of severe and cerebral malaria and identify new targets for adjunctive therapies. * Despite treatment between 10-30% of patients with severe malaria die. * Metabolic acidosis and cerebral malaria are major complications associated with mortality across all age groups. Still, their underlying pathogenesis remains incompletely understood. * Using a metabolomics approach, this study aims to characterise the spectrum of acids accumulating during acidosis, and investigate patterns of metabolic dysregulation associated with coma and seizures.

Conditions

Interventions

TypeNameDescription
OTHERObservation

Timeline

Start date
2015-06-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2015-05-22
Last updated
2018-06-20

Locations

1 site across 1 country: Bangladesh

Source: ClinicalTrials.gov record NCT02451904. Inclusion in this directory is not an endorsement.